Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Core Laboratories Q4 2024 Adj EPS $0.22, Inline, Sales $129.24M Miss $132.44M Estimate

Author: Benzinga Newsdesk | January 29, 2025 05:04pm
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 15.79 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $129.24 million which missed the analyst consensus estimate of $132.44 million by 2.42 percent. This is a 0.80 percent increase over sales of $128.21 million the same period last year.

Posted In: CLB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist